Artificial Intelligence in Medicine Market by Type (Hardware, Services, Software), Application (Disease Diagnosis & Identification, Patient Care, Research & Drug Invention), End User - Global Forecast 2024-2030
Description
Artificial Intelligence in Medicine Market by Type (Hardware, Services, Software), Application (Disease Diagnosis & Identification, Patient Care, Research & Drug Invention), End User - Global Forecast 2024-2030
The Artificial Intelligence in Medicine Market size was estimated at USD 4.44 billion in 2023 and expected to reach USD 5.85 billion in 2024, at a CAGR 31.97% to reach USD 30.97 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Artificial Intelligence in Medicine Market, highlighting leading vendors and their innovative profiles. These include Atomwise, Inc., BenevolentAI, Berg LLC, Bioxcel Therapeutics, Inc., Enlitic Inc., Google LLC by Alphabet Inc., InSilico Medicine, Intel Corporation, International Business Machines Corporation, Microsoft Corporation, NVIDIA Corporation, PathAI, Inc., Recursion Pharmaceuticals, Inc., Tempus Labs, Inc., and Verge Analytics, Inc..
Market Segmentation & Coverage
This research report categorizes the Artificial Intelligence in Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Hardware
Disease Diagnosis & Identification
Accountable Care Organizations & Managed Care Organizations
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Artificial Intelligence in Medicine Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Medicine Market?
- What are the technology trends and regulatory frameworks in the Artificial Intelligence in Medicine Market?
- What is the market share of the leading vendors in the Artificial Intelligence in Medicine Market?
- Which modes and strategic moves are suitable for entering the Artificial Intelligence in Medicine Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Artificial Intelligence in Medicine Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising demand to improve the efficiency of drug discovery
- 5.1.1.2. Increase in need to reduce healthcare costs
- 5.1.1.3. Increased emphasis on adoption of digital transformation practices to realize cost savings
- 5.1.2. Restraints
- 5.1.2.1. Unavailability of skilled professionals
- 5.1.3. Opportunities
- 5.1.3.1. Rising focus on developing human-aware artificial intelligence systems
- 5.1.3.2. Growing importance of precision medicine
- 5.1.4. Challenges
- 5.1.4.1. Growing concerns regarding data privacy
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Artificial Intelligence in Medicine Market, by Type
- 6.1. Introduction
- 6.2. Hardware
- 6.3. Services
- 6.4. Software
- 7. Artificial Intelligence in Medicine Market, by Application
- 7.1. Introduction
- 7.2. Disease Diagnosis & Identification
- 7.3. Patient Care
- 7.4. Research & Drug Invention
- 8. Artificial Intelligence in Medicine Market, by End User
- 8.1. Introduction
- 8.2. Accountable Care Organizations & Managed Care Organizations
- 8.3. Patients
- 8.4. Payers
- 8.5. Pharmaceutical & Biotechnology Companies
- 8.6. Providers
- 9. Americas Artificial Intelligence in Medicine Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Artificial Intelligence in Medicine Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Artificial Intelligence in Medicine Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Atomwise, Inc.
- 13.1.2. BenevolentAI
- 13.1.3. Berg LLC
- 13.1.4. Bioxcel Therapeutics, Inc.
- 13.1.5. Enlitic Inc.
- 13.1.6. Google LLC by Alphabet Inc.
- 13.1.7. InSilico Medicine
- 13.1.8. Intel Corporation
- 13.1.9. International Business Machines Corporation
- 13.1.10. Microsoft Corporation
- 13.1.11. NVIDIA Corporation
- 13.1.12. PathAI, Inc.
- 13.1.13. Recursion Pharmaceuticals, Inc.
- 13.1.14. Tempus Labs, Inc.
- 13.1.15. Verge Analytics, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET RESEARCH PROCESS
- FIGURE 2. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2023 VS 2030
- FIGURE 3. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET DYNAMICS
- FIGURE 7. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
